Professor Kim Moretti

Adjunct Clinical Professor UniSA Allied Health & Human Performance

City East Campus ()
tel +61 8 830 22215

email Kim.Moretti@unisa.edu.au

Research

Research focus

Oncology and Carcinogenesis
Clinical Sciences
Public Health and Health Services
Other Physical Sciences
Biochemistry and Cell Biology

Research

Outputs

Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included.

Open access indicates that an output is open access.

Journal Articles

Year	Output
2025	O'Callaghan, M, Ullah, S, Smith, D, Mark, S, Clarke, J, Rouse, D, David, R & Moretti, K 2025, 'Predicting incontinence and erectile function after prostate cancer surgery: international validation of models', Surgical Oncology, vol. 59, no. , pp. 1-6. 1 1
2025	Tiruye, T, Jay, A, Higgs, B, O'Callaghan, M, FitzGerald, LM, Moretti, K, Roder, D & Beckmann, K 2025, 'Comparing post‑treatment urinary and colorectal procedures in prostate cancer patients using population‑based linked data', International Urology and Nephrology, vol. 57, no. 4, pp. 1189-1198. 2 2
2024	Borg, MA, O'Callaghan, ME, Moretti, KL & Vincent, AD 2024, 'External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects', BMC Urology, vol. 24, no. 1, pp. 1-8. Open access 1 1
2024	Logan, JM, Martini, C, Sorvina, A, Johnson, IR, Brooks, RD, Caruso, MC, Huzzell, C, Moore, CR, Karageorgos, L, Butler, LM, Tewari, P, Prabhakaran, S, Hickey, SM, Klebe, S, Samaratunga, H, Delahunt, B, Moretti, K, O'Leary, JJ, Brooks, DA & Ung, BS 2024, 'Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers', Scientific Data, vol. 11, article no. 852, pp. 1-10. Open access 1
2024	Tiruye, T, O'Callaghan, M, FitgGerald, LM, Moretti, K, Jay, A, Higgs, B, Kichenadasse, G, Caughey, G, Roder, D & Beckmann, K 2024, 'Medication-based comorbidity measures and prostate cancer treatment selection', Clinical Genitourinary Cancer, vol. 22, no. 2, pp. 599-609. Open access 7 7
2024	Tiruye, T, Roder, D, FitzGerald, LM, O'Callaghan, M, Moretti, K & Beckmann, K 2024, 'Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer', Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention, vol. 88, article no. 102516, pp. 1-7. Open access 7 7
2024	Tiruye, T, Roder, D, FitzGerald, LM, O'Callaghan, M, Moretti, K, Caughey, GE & Beckmann, K 2024, 'Impact of comorbidities on prostate cancer‐specific mortality: A population‐based cohort study', Prostate, vol. 84, no. 12, pp. 1138-1145. Open access 9 8 1
2024	Tiruye, TY, O'Callaghan, M, Ettridge, K, Moretti, K, Jay, A, Higgs, B, Santoro, K, Kichenadasse, G & Beckmann, K 2024, 'Clinical and functional outcomes for risk-appropriate treatments for prostate cancer', BJUI Compass, vol. 5, no. 1, pp. 109-120. Open access 10 10 2
2023	Beckmann, KR, O'Callaghan, ME, Vincent, AD, Moretti, KL & Brook, NR 2023, 'Clinical outcomes for men with positive surgical margins after radical prostatectomy-results from the South Australian prostate cancer clinical outcomes collaborative community-based registry', Asian Journal of Urology, vol. 10, no. 4, pp. 502-511. Open access 5 5
2023	Logan, JM, Hopkins, AM, Martini, C, Sorvina, A, Huzzell, C, Johnson, IR, Hickey, SM, Ung, BS-Y, Lazniewska, J, Brooks, RD, Moore, CR, Caruso, MC, Karageorgos, L, Esterman, A, Moretti, K & Brooks, DA and 23 other authors 2023, 'Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-Assisted Grading using Appl1, Sortilin and Syndecan-1', Cancers, vol. 15, no. 12, pp. 1-12. Open access 9 8 122
2023	Martini, C, Logan, JM, Sorvina, A, Gordon, C, Beck, AR, Ung, BS, Caruso, MC, Moore, C, Johnson, IR, Li, KL, Karageorgos, L, Esterman, AJ, Huzzell, C, Brooks, RD, Lazniewska, J, Hickey, SM, Bader, CA, Parkinson-Lawrence, E, Prabhakaran, S, Moretti, KL & Brooks, DA and 28 other authors 2023, 'Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer', Pathology, vol. 55, no. 1, pp. 40-51. Open access 17 16 81
2023	O'Callaghan, ME, Roberts, MJ, Moretti, KL, Frydenberg, M, Gilbourd, D, Mark, S, Heathcote, P, Millar, J, PCOR-ANZ, & Papa, N 2023, 'Variation in patient reported outcomes following radical prostatectomy: a bi-national registry-based study', Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 2, pp. 105.e9-105.e18. 5
2023	Tiruye, T, Ettridge, K, O'Callaghan, M, Moretti, K, Jay, A, Higgs, B, Santoro, K, Kichenadasse, G, Roder, D & Beckmann, K 2023, 'Reporting real-world data on prostate cancer treatment outcomes to consumers: the prostate cancer report card', European Journal of Cancer Care, vol. 2023, article no. 6660371, pp. 1-12. Open access 6 6 57
2023	Tiruye, T, O'Callaghan, M, Ettridge, K, Jay, A, Santoro, K, Moretti, K & Beckmann, K 2023, 'Factors impacting on sexual function among men on active surveillance for prostate cancer', Prostate, vol. 83, no. 7, pp. 678-687. Open access 10 8 5
2023	Tiruye, T, Roder, D, FitzGerald, LM, O'Callaghan, M, Morreti, K & Beckmann, K 2023, 'Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer', Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention, vol. 87, article no. 102482, pp. 1-6. Open access 5 5
2022	Moretti, K 2022, 'Active surveillance for intermediate risk prostate cancer could be risky for the patient', World Journal of Urology, vol. 40, no. 4, pp. 1079-1080.
2022	Tiruye, T, O'Callaghan, M, Moretti, K, Jay, A, Higgs, B, Santoro, K, Boyle, T, Ettridge, K & Beckmann, K 2022, 'Patient-reported functional outcome measures and treatment choice for prostate cancer', BMC Urology, vol. 22, article no. 1, pp. 1-11. Open access 13 13 1
2021	Ettridge, K, Wright, K, Smith, D, Chambers, S, Corsini, N, Evans, S, Moretti, K, Roder, D, Scuffham, P & Miller, C 2021, 'Measuring psychosocial outcomes of men living with prostate cancer: feasibility of regular assessment of patient-reported outcomes', European Journal of Cancer Care, vol. 30, no. 4, article no. e13393, pp. 1-15. 6 5 6
2021	O'Callaghan, M, Papa, N, Pase, M, Frydenberg, M, Mark, S, Moretti, K, Maqsood, S, Smith, D, Walker, T, White, C & Millar, J 2021, 'Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?', BJU International, vol. 128, no. S1, pp. 6-8. 12 12
2021	Soo, A, O'Callaghan, ME, Kopsaftis, T, Vatandoust, S, Moretti, K & Kichenadasse, G 2021, 'PSA response to antiandrogen withdrawal: a systematic review and meta-analysis', Prostate Cancer and Prostatic Diseases, vol. 24, no. 3, pp. 826-836. 3 4
2019	Beckmann, K, O'Callaghan, M, Vincent, A, Cohen, P, Borg, M, Roder, D, Evans, S, Millar, J & Moretti, K 2019, 'Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings', Asian Journal of Urology, vol. 6, no. 4, pp. 321-329. Open access 10 10 1
2019	Forgione, M, Sara, S, Vincent, AD, Borg, M, Moretti, K & O'Callaghan, ME 2019, 'Satisfaction with care in men with prostate cancer', European Journal of Cancer Care, vol. 28, no. 4, article no. e13028, pp. 1-8. 5 5
2019	Lojanapiwat, B, Lee, JY, Gang, Z, Kim, CS, Moretti, K & Akaza, H and 22 other authors 2019, 'Report of the third Asian Prostate Cancer study meeting', Prostate International, vol. 7, no. 2, pp. 60-67. Open access 10 9
2018	Beckmann, K, O'Callaghan, M, Vincent, A, Roder, D, Millar, J, Evans, S, McNeil, J & Moretti, K 2018, 'Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy', ANZ Journal of Surgery, vol. 88 x 1445-1433, no. 3, pp. E183-E188. 2 2 1
2018	Lu, TC, Moretti, K, Beckmann, K, Cohen, P & O'Callaghan, M 2018, 'ISUP Group 4: a homogenous group of prostate cancers?', Pathology and Oncology Research, vol. 24, no. 2, pp. 921-925. 11 11 3
2018	Nag, N, Millar, J, Davis, ID, Costello, S, Roder, D, Moretti, KL & Evans, SM and 18 other authors 2018, 'Development of Indicators to Assess Quality of Care for Prostate Cancer', European Urology Focus, vol. 4, no. 1, pp. 57-63. 19 20 6
2018	Tsiamis, E, Millar, J, Baxi, S, Borg, M, De Ieso, P, Elsaleh, H, Foroudi, F, Higgs, B, Holt, T, Martin, J, Moretti, K, Pryor, D, Skala, M & Evans, S 2018, 'Development of quality indicators to monitor radiotherapy care for men with prostate cancer: a modified Delphi method', Radiotherapy and Oncology, vol. 128, pp. 308-314. 14 14
2018	Vatandoust, S, Kichenadasse, G, O'Callaghan, M, Vincent, AD, Kopsaftis, T, Walsh, S, Borg, M, Karapetis, CS & Moretti, K 2018, 'Localised prostate cancer in elderly men aged 80-89 years, findings from a population-based registry', BJU International, vol. 121, no. S3, pp. 48-54. Open access 19 18
2017	Beckmann, KR, O'Callaghan, ME, Ruseckaite, R, Kinnear, N, Miller, C, Evans, S, Roder, DM & Moretti, K 2017, 'Prostate cancer outcomes for men who present with symptoms at diagnosis', BJU International, vol. 119, no. 6, pp. 862-871. 6 6
2017	Campbell, JM, O'Callaghan, ME, Raymond, E, Vincent, AD, Beckmann, KR, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, KL 2017, 'Tools for predicting clinical and patient-reported outcomes in prostate cancer patients undergoing androgen deprivation therapy: a systematic review of prognostic accuracy and validity', Clinical Genitourinary Cancer, vol. 15, no. 6, pp. 629-634. 7 5 2
2017	Campbell, JM, Raymond, E, O'Callaghan, ME, Vincent, AD, Beckmann, KR, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, KL 2017, 'Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity', Clinical Genitourinary Cancer, vol. 15, no. 5, pp. e827-e834. 23 22 1
2017	Kim, C-S, Lee, JY, Chung, BH, Kim, W-J, Moretti, K & Akaza, H 2017, 'Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting', Prostate International, vol. 95, no. 3, pp. 95-103. Open access 10 10
2017	O'Callaghan, M, Raymond, E, Campbell, J, Vincent, A, Beckmann, K, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, K 2017, 'Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity', Prostate Cancer and Prostatic Diseases, vol. 20, no. 4, pp. 378-388. 21 18 2
2017	O'Callaghan, ME, Raymond, E, Campbell, JM, Vincent, AD, Beckmann, K, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, K 2017, 'Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity', International Journal of Radiation Oncology Biology Physics, vol. 98, no. 2, pp. 318-337. 11 10 2
2017	O'Callaghan, ME, Shi, Z, Kopsaftis, T & Moretti, K 2017, 'Prostate cancer outcomes and delays in care', International Urology and Nephrology, 49, no. 3, pp. 449-455. 9 9
2017	Raymond, E, O'Callaghan, ME, Campbell, J, Vincent, AD, Beckmann, KR, Roder, DM, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, K 2017, 'An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review', Radiation Oncology, vol. 12, article no. 56, pp. 1-20. Open access 14 14 3
2016	Ang, M, Rajcic, B, Foreman, D, Moretti, K & O'Callaghan, ME 2016, 'Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL', BJU International, vol. 117, no. S4, pp. 68-75. Open access 5 25
2016	Evans, SM, Nag, N, Roder, D, Brooks, A, Millar, JL, Moretti, KL, Pryor, D, Skala, M & McNeil, JJ 2016, 'Development of an international prostate cancer outcomes registry', BJU International, vol. 117, S4, pp. 60-67. Open access 36 36 4
2016	Gandaglia, G, Bray, F, Cooperberg, MR, Karnes, RJ, Leveridge, MJ, Moretti, K, Murphy, DG, Penson, DF & Miller, DC 2016, 'Prostate cancer registries: current status and future directions', European Urology, vol. 69, no. 6, pp. 998-1012. 61 53
2016	Ruseckaite, R, Beckmann, K, O'Callaghan, M, Roder, D, Moretti, K, Millar, J & Evans, S 2016, 'A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease', BMC Cancer, vol. 16, article no. 607, pp. 1-11. Open access 24 25 11
2016	Ruseckaite, R, Beckmann, K, O'Callaghan, M, Roder, DM, Moretti, K, Zalcberg, J, Millar, J & Evans, S 2016, 'Development of South Australian-Victorian prostate cancer health outcomes research dataset', BMC Research Notes, vol. 9, no. 37 pp. 1 - 11. Open access 5 1
2013	Shi, Z, Pinnock, CB, Kinsey-Trotman, S, Borg, M, Moretti, KL, Walsh, S & Kopsaftis, T 2013, 'Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death', Radiotherapy and Oncology, vol. 107, no. 2, pp. 129-133. 19 18

Reports

Year	Output
2023	Tiruye, T, O'Callaghan, M, Moretti, K, Ettridge, K, Santoro, K & Beckmann, K 2023, Prostate cancer outcomes report card, SA-PCCOC website, Australia. Open access

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Adelaide Radiotherapy Centre	AUSTRALIA
Alan Walker Cancer Care Centre	AUSTRALIA
Alfred Health	AUSTRALIA
Austin Hospital	AUSTRALIA
Australian National University	AUSTRALIA
Beijing United Family Hospital and Clinics	CHINA
Calvary Mater Hospital	AUSTRALIA
Canberra Hospital	AUSTRALIA
Cancer Council NSW	AUSTRALIA
Catholic University of Korea	KOREA, REPUBLIC OF (SOUTH)
Chiang Mai University	THAILAND
Christchurch Hospital	NEW ZEALAND
Chungbuk National Medical University Hospital	KOREA, REPUBLIC OF (SOUTH)
Debre Markos University	ETHIOPIA
Eastern Health	AUSTRALIA
Flinders Medical Centre	AUSTRALIA
Flinders University	AUSTRALIA
Genesis Cancer Care	AUSTRALIA
Griffith University	AUSTRALIA
International Agency for Research on Cancer	FRANCE
Malaghan Institute of Medical Research	NEW ZEALAND
Mayo Clinic	UNITED STATES
Monash University	AUSTRALIA
Northern Adelaide Local Health Network	AUSTRALIA
Olivia Newton John Cancer Research and Wellness Centre	AUSTRALIA
Prepatriation Hospital	AUSTRALIA
Princess Alexandra Hospital	AUSTRALIA
Qatar University	QATAR
Queen's University	CANADA
Queensland University of Technology	AUSTRALIA
Repatriation General Hospital	AUSTRALIA
Royal Adelaide Hospital	AUSTRALIA
Royal Brisbane and Women's Hospital	AUSTRALIA
SA Pathology	AUSTRALIA
San Raffaele Hospital	ITALY
South Australian Health and Medical and Research Institute (SAHMRI)	AUSTRALIA
South Australian Health and Medical Institute	AUSTRALIA
South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC)	AUSTRALIA
Southern Adelaide Local Health Network (SALHN)	AUSTRALIA
Southern Cancer Network	UNITED STATES
The Alfred Hospital	AUSTRALIA
Trinity College Dublin	IRELAND
University of Adelaide	AUSTRALIA
University of California San Francisco	UNITED STATES
University of Melbourne	AUSTRALIA
University of Michigan	UNITED STATES
University of Queensland	AUSTRALIA
University of South Australia	AUSTRALIA
University of Sydney	AUSTRALIA
University of Tasmania	AUSTRALIA
University of Technology Sydney	AUSTRALIA
University of Tokyo	JAPAN
University of Ulsan	KOREA, REPUBLIC OF (SOUTH)
University of Ulsan College of Medicine	KOREA, REPUBLIC OF (SOUTH)
Vanderbilt University	UNITED STATES
Victoria University	AUSTRALIA
W P Holman Clinic	AUSTRALIA
Westmead Hospital	AUSTRALIA
Yonsei University	KOREA, REPUBLIC OF (SOUTH)

more less

Professor Kim Moretti

About me

About me

UniSA Allied Health & Human Performance

About me

Professional Associations

Experience

Qualifications

Research

Research focus

Projects

Outputs

Journal Articles

Reports

External engagement & recognition

Collaborations

Collaborations

Gallery